Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK.LN | ||||
| Company | Gsk Plc | ||||
| Price Information | |||||
| Exchange | LSE | ||||
| Open | 2,141.000 | ||||
| High | 2,167.000 | ||||
| Low | 2,123.964 | ||||
| Latest | 2,167.000 | ||||
| Change | +42.000 | ||||
| % Change | +1.98% | ||||
| Volume | 6,623,664 | ||||
| 20-Day Average Volume | 8,945,931 | ||||
| Previous Close | 2,125.000 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 2,043.800 | ||||
| 20-Day Raw Stochastic | 100.00% | ||||
| 20-Day Relative Strength | 61.10 | ||||
| Weighted Alpha | +68.36 | ||||
| Today's Opinion | 88% Buy | ||||
| Previous Opinion | 80% Buy | ||||
| Last Month's Opinion | 80% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.99% since 03/31/26 | ||||
| Low | 2,072.000 on 04/01/26 | ||||
| High | 2,167.000 on 04/09/26 | ||||
| 1-Month | |||||
| %Chg | +5.91% since 03/09/26 | ||||
| Low | 1,906.280 on 03/23/26 | ||||
| High | 2,167.000 on 04/09/26 | ||||
| 3-Month | |||||
| %Chg | +14.90% since 01/09/26 | ||||
| Low | 1,774.000 on 01/20/26 | ||||
| High | 2,282.000 on 02/18/26 | ||||
| 6-Month | |||||
| %Chg | +32.13% since 10/09/25 | ||||
| Low | 1,592.000 on 10/24/25 | ||||
| High | 2,282.000 on 02/18/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 83,766,890 | ||||
| Shares Outstanding, K | 3,996,847 | ||||
| Annual Sales | 32,667,000,000 | ||||
| Annual Net Income | 5,716,000,000 | ||||
| Last Quarter Sales | 8,618,000,000 | ||||
| Last Quarter Net Income | 636,000,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | 0.16 on 02/04/26 | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | 0.180 on 02/19/26 | ||||
| Next Ex-Dividends Date | 02/19/26 | ||||
| Ratios | |||||
| Price/Earnings ttm | 15.10 | ||||